, the CCCT test had a 85% accuracy in preBasal follicle-stimulating hormone (FSH) and age have dicting poor response to gonadotropin-induced conlong been recognized as prognostic indicators of fecuntrolled ovarian hyperstimulation for IVF. A similar dity (1-5). In 1991, Toner et al. (4) concluded that study utilized the FSH values obtained from the CCCT and concluded that the CCCT had a 100% success rate in predicting pregnancy failure in IVF (11).
supported the use of both age and FSH in predicting determine which indicator of ovarian reserve-basal (day fertility potential. A similar finding was advanced by
3) FSH or the CCCT-is the better predictor of IVF success

Scott et al. (6).
in the critical age group of women over the age of 40. (12) . pregnancy rate, while the other 7 pregnancies occurred on the second attempt, representing a 13.2% pregnancy The CCCT was performed by the collection of a baseline FSH drawn on menstrual cycle day 3 and a rate. No pregnancies resulted from the third, fourth, or fifth IVF attempts. stimulated FSH level on menstrual day 10 after the patient took 100 mg clomiphene citrate (Clomid, MarThe mean basal FSH level was 8.0 Ϯ 2.9 mIU/ml, and in the 69 women who had completed a CCCT the ion Merrell Dow Inc., Kansas City, MO, or Serophene, Serono Labs Inc., Randolph, MA) on cycle days 5-9. mean day 3 and day 10 FSH were 8.3 Ϯ 2.5 and 8.7 Ϯ 3.7 mIU/ml, respectively. There was no statistically FSH was measured using the Technicon Immuno 1 System (Bayer Corporation, Tarrytown, NY). The significant difference in day 3 FSH and day 10 FSH following a CCCT between patients who became pregaverage inter-and intracoefficients of variation (CV) were 3.3% and 1.9%, respectively. nant and those who did not achieve pregnancy (Table  I) . Importantly, no patient with a day 3 FSH greater Women who used ART procedures other than IVF or received donated oocytes were excluded. Ongoing than 11.1 mIU/ml or a day 10 FSH greater than 13.5 mIU had an ongoing pregnancy. pregnancy was defined as a continuing pregnancy at a gestational age of Ն20 weeks. Women with biochemThere was no significant difference in pregnancy rates by patient age (P ϭ 0.18) (Table II) . Even when ical or ectopic pregnancies, stillbirths, or spontaneous abortions were classified as not pregnant. patients were grouped into younger patients in this population (ages 40-41) and older patients (ages 42-The IVF stimulation protocol used a gonadotropinreleasing hormone (GnRH) agonist to achieve pituitary 44), there was no difference in pregnancy rates, 14.8% and 10%, respectively (P ϭ 0.77). down-regulation followed by controlled ovarian hyper- come poor oocyte quality, it seems logical to assume that couples with an infertile male and a reproductively healthy female are more likely to conceive through IVF (or IVF with ICSI) than is a couple with a woman Among the 40 patients in couples with a diagnosis of male factor, 9 (22.5%) conceived; 4 on the first who has poor oocyte quality as a contributing cause for infertility but has a reproductively healthy male attempt and 5 in the second cycle. In contrast, only 8 of 64 (12.5%) cycles in non-male factor couples partner. Although this study found clear prognostic cutoff resulted in a pregnancy (P ϭ 0.377) (Fig. 1) . Among the 22 women with tubal factor infertility, 3 achieved values for FSH within the narrow 40-to 44-year-old infertility population, there was no statistically signifia pregnancy (13.6%); 2 in the first cycle and 1 in the second. There were 16 pregnancies in the 82 (19.5%) cant difference in FSH levels among successful and unsuccessful patients. This latter result may be due non-tubal factor patients (P ϭ 0.757) (Fig. 1) .
Although basal FSH testing has been proven to have
A Kaplan-Meier life table analysis was carried out to the small number of pregnancies studied. Another possible explanation for the apparent lack of statistical for all diagnoses as well as for male factor and tubal factor patients. Overall, the estimated average number significance could be the restricted age parameters of this study. All women beginning all IVF treatments of IVF attempts needed to achieve pregnancy was 1.69. The life table analysis (Fig. 1) shows that the overall were over the age of 40. If the age parameters were relaxed or comparison was made with a wide range cumulative probability of pregnancy was 0.12 on the first attempt and 0.23 on the second attempt. All pregof ages statistical significance might be observed. Even more interesting is the fact there was no statistically nancies occurred as a result of either the first or second IVF attempt.
significant difference between the pregnant and nonpregnant patients based on basal day 3 FSH and the stimulated day 10 FSH results. This suggests that a CCCT is no more useful than day 3 FSH levels in DISCUSSION predicting IVF outcome in women over 40. When comparison is made between this retrospecThis study examined the clinical utility of the CCCT in a population of advanced reproductive-age women tive investigation and other clinical undertakings, the manner and controls used to produce this population (all began treatment after age 40) undergoing IVF. While there was overlap between day 3 and day 10 become important. All the women in this study were aged 40 or older before beginning FSH testing or IVF. FSH levels in successful and unsuccessful patients, clear prognostic cutoff values for FSH were identified.
Women who completed initial cycles in their late 30s and subsequent cycles in their 40s were excluded. No patient carried a pregnancy past 20 weeks with a day 3 FSH greater than 11.1 mIU/ml or a stimulated When Hofmann et al. (8) developed screening criteria for testing ovarian reserve, they advocated testing all women Ͼ35 years old. That study showed positive 
